Core Insights - ResMed reported revenue of $1.34 billion for the quarter ended September 2025, reflecting a 9.1% increase year-over-year and a surprise of +0.94% over the Zacks Consensus Estimate of $1.32 billion [1] - Earnings per share (EPS) for the quarter was $2.55, up from $2.20 in the same quarter last year, with an EPS surprise of +2.41% compared to the consensus estimate of $2.49 [1] Revenue Performance - U.S., Canada, and Latin America - Devices revenue was $413.4 million, exceeding the average estimate of $409.2 million, representing a year-over-year increase of +7.5% [4] - U.S., Canada, and Latin America - Masks and other revenue reached $361.3 million, surpassing the average estimate of $355.76 million, with a year-over-year change of +11.9% [4] - Combined Europe, Asia, and other markets - Total revenue was $394.7 million, above the average estimate of $385.76 million, reflecting a +9.5% change year-over-year [4] - Combined Europe, Asia, and other markets - Devices revenue was $266.9 million, exceeding the average estimate of $257.17 million, with a year-over-year increase of +10.6% [4] - Combined Europe, Asia, and other markets - Masks and other revenue was $127.8 million, slightly below the average estimate of $128.59 million, showing a +7.2% year-over-year change [4] - U.S., Canada, and Latin America - Total revenue was $774.8 million, exceeding the average estimate of $764.96 million, representing a +9.5% change year-over-year [4] - Global revenue for Total Sleep and Breathing Health was $1.17 billion, surpassing the average estimate of $1.15 billion, with a +9.5% year-over-year change [4] - Global revenue for Residential Care Software was $166.1 million, below the average estimate of $170.38 million, reflecting a +5.9% year-over-year change [4] - Global revenue for Total Devices was $680.3 million, exceeding the average estimate of $666.36 million, with a year-over-year increase of +8.7% [4] - Global revenue for Total Masks and other was $489.1 million, surpassing the average estimate of $484.35 million, showing a +10.7% year-over-year change [4] Stock Performance - ResMed's shares have returned -6.4% over the past month, while the Zacks S&P 500 composite has increased by +3.6% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Core Insights - AtriCure reported $134.27 million in revenue for Q3 2025, a 15.8% year-over-year increase, with an EPS of -$0.01 compared to -$0.17 a year ago, indicating significant improvement in profitability [1] - The revenue exceeded the Zacks Consensus Estimate by 2.09%, while the EPS surprise was 90.91% above the consensus estimate [1] Revenue Performance - U.S. revenue from pain management reached $20.84 million, surpassing the average estimate of $20.59 million, reflecting a 27.7% year-over-year increase [4] - International revenue from pain management was $2.08 million, below the average estimate of $2.77 million, but still showing a 30.8% year-over-year increase [4] - U.S. revenue from total ablation was $43.02 million, significantly below the average estimate of $63.41 million, marking a 25.9% year-over-year decline [4] - International revenue from total ablation was $12.71 million, slightly below the average estimate of $14.54 million, but showing a 7% year-over-year increase [4] - Total U.S. revenue was $109.31 million, exceeding the average estimate of $106.47 million, with a 14.5% year-over-year increase [4] - International revenue from appendage management was $10.17 million, below the average estimate of $10.58 million, reflecting an 18.5% year-over-year increase [4] - U.S. revenue from open ablation was $35.59 million, slightly above the average estimate of $34.88 million, with a 16.3% year-over-year increase [4] - International revenue from open ablation was $10.85 million, exceeding the average estimate of $9.73 million, marking a 26.1% year-over-year increase [4] - U.S. revenue from minimally invasive ablation was $7.43 million, below the average estimate of $7.94 million, showing a 33.2% year-over-year decline [4] - International revenue from minimally invasive ablation was $1.86 million, below the average estimate of $2.04 million, but reflecting a 10.8% year-over-year increase [4] - U.S. revenue from appendage management was $45.45 million, exceeding the average estimate of $43.06 million, with a 21.5% year-over-year increase [4] - Total international revenue was $24.96 million, slightly below the average estimate of $25.12 million, but showing a 22% year-over-year increase [4] Stock Performance - AtriCure's shares have returned 3.4% over the past month, compared to a 3.8% change in the Zacks S&P 500 composite, indicating a performance in line with the broader market [3]

Core Insights - Shore Bancshares reported revenue of $56.36 million for the quarter ended September 2025, reflecting an 11.5% increase year-over-year, although it was a slight miss of 0.4% compared to the Zacks Consensus Estimate of $56.58 million [1] - The earnings per share (EPS) for the quarter was $0.48, up from $0.40 in the same quarter last year, resulting in a positive surprise of 6.67% against the consensus estimate of $0.45 [1] Financial Performance Metrics - Net Interest Margin stood at 3.4%, matching the two-analyst average estimate of 3.4% [4] - Efficiency Ratio was reported at 61%, slightly better than the two-analyst average estimate of 61.1% [4] - Total Non-Interest Income was $7.7 million, below the two-analyst average estimate of $7.95 million [4] - Net Interest Income reached $48.66 million, exceeding the two-analyst average estimate of $48.22 million [4] Stock Performance - Over the past month, shares of Shore Bancshares have returned -6.2%, contrasting with the Zacks S&P 500 composite's increase of +0.2% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

Core Insights - ServisFirst Bancshares reported revenue of $136.28 million for the quarter ended September 2025, reflecting a year-over-year increase of 10.2% but falling short of the Zacks Consensus Estimate by 8.41% [1] - The earnings per share (EPS) for the quarter was $1.30, an increase from $1.10 in the same quarter last year, but below the consensus estimate of $1.38, resulting in an EPS surprise of -5.8% [1] Financial Performance Metrics - Efficiency Ratio was reported at 35.2%, higher than the average estimate of 31.5% from two analysts [4] - Net charge-offs to total average loans stood at 0.3%, compared to the average estimate of 0.2% [4] - Net Interest Margin was 3.1%, slightly below the estimated 3.2% [4] - Average Balance of Interest-earning Assets was $17.13 billion, lower than the average estimate of $17.39 billion [4] - Net Interest Income was reported at $133.45 million, below the average estimate of $139.64 million [4] - Total Non-interest income was $2.83 million, significantly lower than the average estimate of $9.15 million [4] - Credit card income was $2.41 million, exceeding the average estimate of $2.28 million [4] - Service charges on deposit accounts reached $3.32 million, above the average estimate of $2.73 million [4] - Mortgage banking income was $1.86 million, higher than the estimated $1.28 million [4] - Other Operating Income was reported at $0.66 million, slightly below the average estimate of $0.83 million [4] Stock Performance - Shares of ServisFirst have declined by 10.7% over the past month, contrasting with a 1.1% increase in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]

Group 1 - Carnival reported $8.15 billion in revenue for the quarter ended August 2025, a year-over-year increase of 3.3% [1] - EPS for the same period was $1.43, compared to $1.27 a year ago, representing an EPS surprise of +8.33% over the consensus estimate of $1.32 [1] - The reported revenue exceeded the Zacks Consensus Estimate of $8.07 billion by +0.99% [1] Group 2 - Key metrics monitored include ALBDs at 24.6 million, occupancy percentage at 112%, and passenger cruise days (PCDs) at 27.5 million [4] - Fuel cost per metric ton consumed was reported at $607.00, higher than the estimated $595.27 [4] - Net yields per ALBD were $249.11, surpassing the average estimate of $247.58 [4] Group 3 - Revenues from onboard and other sources were $2.72 billion, exceeding the average estimate of $2.66 billion, with a year-over-year change of +2.5% [4] - Revenues from passenger tickets reached $5.43 billion, compared to the average estimate of $5.34 billion, reflecting a year-over-year change of +3.7% [4] - Carnival's stock has returned -4% over the past month, while the Zacks S&P 500 composite increased by +2.9% [3]

Financial Performance - For the quarter ended August 2025, AutoZone reported revenue of $6.24 billion, reflecting a 0.6% increase year-over-year [1] - Earnings per share (EPS) were $48.71, up from $48.11 in the same quarter last year [1] - The reported revenue exceeded the Zacks Consensus Estimate of $6.22 billion by 0.35%, while the EPS fell short of the consensus estimate of $50.52 by 3.58% [1] Key Metrics - Domestic same-store sales increased by 4.8%, surpassing the six-analyst average estimate of 3.2% [4] - Total same-store sales in constant currency were up 5.1%, compared to the estimated 4.7% by five analysts [4] - The total square footage of stores was 51,818.00 Ksq ft, slightly below the average estimate of 51,899.48 Ksq ft [4] - The number of domestic stores reached 6,627, exceeding the three-analyst average estimate of 6,591 [4] - International same-store sales grew by 2.1%, significantly better than the -0.8% estimated by two analysts [4] Stock Performance - AutoZone shares returned -0.5% over the past month, while the Zacks S&P 500 composite increased by 3.6% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market [3]

Core Insights - Victoria's Secret reported revenue of $1.46 billion for the quarter ended July 2025, marking a year-over-year increase of 3% and a surprise of +3.78% over the Zacks Consensus Estimate of $1.41 billion [1] - The company's EPS for the same period was $0.33, down from $0.40 a year ago, but exceeded the consensus estimate of $0.13 by +153.85% [1] Financial Performance - Comparable sales for stores and direct channels increased by 4%, significantly outperforming the estimated -0.4% by analysts [4] - The total number of company-operated stores was 787, slightly below the average estimate of 793 from two analysts [4] - The total number of stores in the China joint venture was 63, compared to the estimated 70 by two analysts [4] - Geographic net sales for direct channels were reported at $406.5 million, which is lower than the average estimate of $415.58 million, reflecting a year-over-year decline of -5.5% [4] Stock Performance - Over the past month, shares of Victoria's Secret have returned +16.7%, outperforming the Zacks S&P 500 composite's +1.5% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

Group 1 - Oneok Inc. reported $7.89 billion in revenue for Q2 2025, a year-over-year increase of 61.2%, with EPS of $1.34 compared to $1.33 a year ago [1] - The reported revenue was below the Zacks Consensus Estimate of $8.56 billion, resulting in a surprise of -7.91%, while the EPS met the consensus estimate [1] - Over the past month, Oneok's shares returned -6.7%, contrasting with the Zacks S&P 500 composite's +1.9% change, and the stock holds a Zacks Rank 3 (Hold) [3] Group 2 - Raw feed throughput for Natural Gas Liquids was 1,527.00 MBBL/d, below the average estimate of 1,702.67 MBBL/d [4] - Revenues from Natural Gas Gathering and Processing reached $1.85 billion, significantly exceeding the average estimate of $1.37 billion, representing a year-over-year change of +118.4% [4] - Revenues from Natural Gas Pipelines were $405 million, surpassing the estimated $161.26 million, with a year-over-year increase of +148.5% [4] - Revenues from Refined Products & Crude totaled $2.91 billion, well above the average estimate of $992.77 million [4] - Revenues from Natural Gas Liquids amounted to $3.87 billion, exceeding the average estimate of $3.06 billion, with a year-over-year change of +9.7% [4] - Adjusted EBITDA for Natural Gas Liquids was $673 million, slightly below the estimated $725 million [4] - Adjusted EBITDA for Refined Products & Crude was $557 million, slightly above the average estimate of $549.48 million [4] - Adjusted EBITDA for Natural Gas Pipelines reached $188 million, exceeding the average estimate of $145.59 million [4] - Adjusted EBITDA for Natural Gas Gathering and Processing was $540 million, in line with the average estimate of $538.82 million [4]

Core Insights - ConocoPhillips reported revenue of $14.74 billion for the quarter ended June 2025, reflecting a 4.3% increase year-over-year, but fell short of the Zacks Consensus Estimate by 1.25% [1] - The company's EPS was $1.42, down from $1.98 in the same quarter last year, but exceeded the consensus estimate of $1.36 by 4.41% [1] Financial Performance - Total production per day was 2,391 million barrels of oil equivalent, surpassing the eight-analyst average estimate of 2,362.71 million barrels [4] - Natural gas production was 4,005 million cubic feet per day, exceeding the seven-analyst average estimate of 3,985.42 million cubic feet [4] - Crude oil production was 1,155 million barrels per day, slightly above the six-analyst average estimate of 1,153.05 million barrels [4] - Sales and other operating revenues were reported at $14 billion, lower than the five-analyst average estimate of $14.68 billion, but showed a year-over-year increase of 2.8% [4] - Equity in earnings of affiliates was $315 million, exceeding the four-analyst average estimate of $259.2 million, but represented a year-over-year decline of 21.8% [4] Market Performance - ConocoPhillips shares returned -1.5% over the past month, while the Zacks S&P 500 composite increased by 1.2% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market [3]

Core Insights - Aflac reported revenue of $4.54 billion for the quarter ended June 2025, reflecting an 11.7% decrease year-over-year, but exceeded the Zacks Consensus Estimate by 2.3% [1] - Earnings per share (EPS) for the quarter was $1.78, down from $1.83 in the same quarter last year, surpassing the consensus EPS estimate of $1.71 by 4.09% [1] Financial Performance Metrics - Aflac Japan's Total Benefit/Premium was 66.5%, exceeding the average estimate of 65.3% [4] - Aflac U.S. Total Adjusted Expenses/Total Adjusted Revenue was 36.3%, better than the average estimate of 38.1% [4] - Aflac U.S. Total Adjusted Revenues were reported at $1.73 billion, slightly below the estimated $1.74 billion, but showed a year-over-year increase of 2.6% [4] - Aflac Japan's Total Adjusted Revenues were $2.47 billion, surpassing the estimate of $2.38 billion, with a year-over-year change of 1% [4] - Total net earned premiums for Aflac U.S. were $1.5 billion, compared to the estimate of $1.52 billion, reflecting a 3.4% increase year-over-year [4] - Other income for Aflac Japan was reported at $12 million, significantly higher than the estimated $6.67 million, marking a 71.4% year-over-year increase [4] - Net investment income was $1.08 billion, slightly below the estimate of $907.26 million, showing a 1.3% decrease year-over-year [4] - Total net earned premiums across the company were $3.47 billion, exceeding the estimate of $3.44 billion, with a year-over-year increase of 4.4% [4] - Corporate and other adjusted revenues were $336 million, surpassing the average estimate of $328.5 million, representing a 34.9% year-over-year change [4] Stock Performance - Aflac's shares have returned -4.2% over the past month, contrasting with a +1% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]